| TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies SJ Klug, M Ressing, J Koenig, MC Abba, T Agorastos, SMF Brenna, ... The lancet oncology 10 (8), 772-784, 2009 | 173 | 2009 |
| The characteristics of human papillomavirus DNA in head and neck cancers and papillomas T Major, K Szarka, I Sziklai, L Gergely, J Czegledy Journal of clinical pathology 58 (1), 51-55, 2005 | 145 | 2005 |
| Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. G Veress, K Szarka, XP Dong, L Gergely, H Pfister Journal of General Virology 80 (4), 1035-1043, 1999 | 138 | 1999 |
| Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential K Szarka, I Tar, E Fehér, T Gáll, A Kis, ED Tóth, R Boda, I Márton, ... Oral microbiology and immunology 24 (4), 314-318, 2009 | 123 | 2009 |
| Epstein–Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population A Kis, E Fehér, T Gáll, I Tar, R Boda, ED Tóth, G Méhes, L Gergely, ... European journal of oral sciences 117 (5), 536-540, 2009 | 105 | 2009 |
| Survivin promoter polymorphism and cervical carcinogenesis AA Borbély, M Murvai, K Szarka, J Kónya, L Gergely, Z Hernádi, G Veress Journal of clinical pathology 60 (3), 303-306, 2007 | 99 | 2007 |
| High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma G Szládek, A Juhász, G Kardos, K Szőke, T Major, I Sziklai, I Tar, I Márton, ... Journal of clinical pathology 58 (4), 402-405, 2005 | 56 | 2005 |
| Prevalence of HPV infection in racial–ethnic subgroups of head and neck cancer patients C Ragin, JC Liu, G Jones, O Shoyele, B Sowunmi, R Kennett, D Gibbs, ... Carcinogenesis 38 (2), 218-229, 2017 | 48 | 2017 |
| Additional human papillomavirus types detected by the hybrid capture tube test among samples from women with cytological and colposcopical atypia J Kónya, G Veress, A Juhász, K Szarka, T Sápy, Z Hernádi, L Gergely Journal of clinical microbiology 38 (1), 408-411, 2000 | 46 | 2000 |
| Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers. K Szarka, G Veress, A Juhasz, J Konya, T Sapy, G Soos, Z Hernadi, ... Anticancer research 20 (3B), 2161-2167, 2000 | 42 | 2000 |
| The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up Z Hernádi, K Szarka, T Sápy, Z Krasznai, G Veress, R Póka BJOG: an international journal of obstetrics and gynaecology 110 (2), 205-209, 2003 | 35 | 2003 |
| Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region G Veress, M Murvai, K Szarka, A Juhasz, J Konya, L Gergely European Journal of Cancer 37 (15), 1946-1952, 2001 | 33 | 2001 |
| Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students KG Ebrahimi F, Mózes J, Monostori J, Gorácz O, Fésűs A, Majoros L, Szarka K Microbiology and Immunology 60 (5), 285-94, 2016 | 32 | 2016 |
| Persisting TT virus (TTV) genogroup 1 variants in renal transplant recipients G Szladek, A Juhasz, L Asztalos, K Szöke, M Murvai, K Szarka, G Veress, ... Archives of virology 148, 841-851, 2003 | 26 | 2003 |
| Asymptomatic faecal carriage of ESBL producing enterobacteriaceae in Hungarian healthy individuals and in long-term care applicants: A shift towards CTX-M producers in the … F Ebrahimi, J Mózes, J Mészáros, Á Juhász, L Majoros, K Szarka, ... Infectious Diseases 48 (7), 557-559, 2016 | 21 | 2016 |
| Investigation of the occurrence of torque tenovirus in malignant and potentially malignant disorders associated with human papillomavirus E Fehér, T Gáll, M Murvai, A Kis, R Boda, T Sápy, I Tar, L Gergely, ... Journal of medical virology 81 (11), 1975-1981, 2009 | 21 | 2009 |
| Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase … P Girardi, S Harutyunyan, I Neuhauser, K Glaninger, O Korda, G Nagy, ... Vaccines 10 (2), 340, 2022 | 20 | 2022 |
| Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: complete genome … T Gáll, A Kis, E Fehér, L Gergely, K Szarka Antiviral research 92 (2), 356-358, 2011 | 20 | 2011 |
| Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer. K Szarka, G Veress, J Konya, L Gergely Anticancer research 19 (3B), 2377-2379, 1999 | 19 | 1999 |
| Utilization of vector autoregressive and linear transfer models to follow up the antibiotic resistance spiral in gram-negative bacteria from cephalosporin consumption to … H Tóth, A Fésűs, O Kungler-Gorácz, B Balázs, L Majoros, K Szarka, ... Clinical Infectious Diseases 69 (8), 1410-1421, 2019 | 18 | 2019 |
György VeressUniversity of Debrecen, Faculty of Medicine, Department of Medical MicrobiologyVerified email at med.unideb.hu
